挪威发现脑卒中患者患癫痫的风险增加

 
在挪威研究人员进行的一项长期随访临床研究中，涉及了大约500例患者的资料显示：3.1％的患者患上了癫痫。这项研究结果在2005年8月期的《癫痫》杂志上进行了报道。

在研究中，重度脑卒中患者在脑卒中发作后，患上癫痫的风险比脑卒中程度较轻的患者要高出5倍。脑卒中发作后患上癫痫的风险，并不受到特定脑卒中治疗机构治疗方案、脑卒中起病年纪、或者地理区域的影响。对医疗工作人员而言，清醒认识到脑卒中发作后的风险是十分重要的。如果在脑卒中患者中检查到癫痫发作，应当给予抗癫痫药物治疗，这样通常可以有效地防止进一步地癫痫发作。

挪威国家癫痫中心教育与研究系主任Morten I. Lossius说：“开展进一步的研究探讨新地治疗方法，比如急性溶栓治疗是否能够减少脑卒中后地癫痫发作，是十分重要的。”正是该机构开展了这项研究。

Lossius医生补充说：“改进脑卒中患者目前被认为金标准的治疗方法同样十分重要，除了溶栓治疗之外，新型神经保护药物与改进溶栓治疗方法，在未来地治疗中具有重要作用。”
Epilepsy Risk Found in Stroke Patients
 
A long follow-up study by researchers in Norway involving data from almost 500 patients has shown that 3.1% of stroke patients develop epilepsy. The finding was reported in the August 2005 issue of Epilepsia.

In the study, those patients who had severe strokes had five times the risk of developing epilepsy post-stroke compared to those with less-severe strokes. The risk of developing epilepsy after a stroke was not found to be influenced by treatment in a specialized stroke unit, age at onset of stroke, or geographical location. It is important for healthcare workers to be aware of this post-stroke risk. If they detect epileptic seizures in stroke patients, they can administer anti-epileptic drugs, which are often effective in preventing further seizures.

“It is important to perform further studies to find out whether newer treatments, such as acute thrombolysis can reduce the frequency of post-stroke epilepsy,” observed Morten I. Lossius, director of the department for education and research at the National Center for Epilepsy in Norway (Sandvika), which conducted the study.

“It is also important to try to improve the treatment of stroke patients beyond what today are known as the gold standards, which apart from thrombolysis, was followed in our study,” added Dr. Lossius. “New neuroprotective drugs and increased use of thrombolysis may play an important role in future treatment.”